Fenofibrate Capsule
Product Images NDC 59651-203

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 59651-203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (67 mg (100 Capsules Bottle))

Fenofibrate Capsules USP 67 mg oral capsules label by Aurobindo Pharma Limited. The label highlights the NDC 59651-201-01, quantity of 100 capsules, and usage instructions including storage and warnings. It states each capsule contains 67 mg of micronized Fenofibrate USP. Distributed by Aurobindo Pharma USA, Inc., made in India.*

FDA Label Image

Package Label-principal Display Panel (134 mg (100 Capsules Bottle))

Label for Fenofibrate Capsules USP 134 mg by Aurobindo Pharma USA, Inc. The label indicates a quantity of 100 capsules. It displays storage instructions, dosage form as oral capsules, and a barcode. The label includes warnings about seal integrity and keeping out of children's reach. Manufactured in India and distributed by Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label-principal Display Panel (200 mg (100 Capsules Bottle))

Fenofibrate Capsules USP 200 mg oral capsules label by Aurobindo Pharma USA, Inc. The label indicates 100 capsules per container. It includes dosage strength, storage instructions, a barcode, and distributor address in New Jersey. The label states the capsules contain Fenofibrate USP (Micronized) at 200 mg, with directions to store in a controlled room temperature environment and warnings about seal integrity and child safety.*

FDA Label Image

Chemical Structure (Fenofibrate Str)

Chemical structure of fenofibrate, a lipid-lowering agent. The structure shows a chlorophenyl group, ester linkages, and isopropyl and methyl substituents consistent with fenofibrate's molecular design.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.